Atai Life Sciences N.V. (ATAI)

Atai Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.29	17.51	45.03	190.61	362.27	97.25
Short-Term Investments	49.92	44.83	134.22	82.5	-	-
Cash & Short-Term Investments	98.2	62.33	179.26	273.11	362.27	97.25
Cash Growth	-7.57%	-65.23%	-34.36%	-24.61%	272.52%	223.48%
Other Receivables	1.49	1.35	1.75	5.63	5.41	1.07
Receivables	1.49	1.35	2.26	5.63	6.32	1.29
Prepaid Expenses	0.39	0.77	1.41	2.03	3.05	0.14
Restricted Cash	10	10	-	-	-	-
Other Current Assets	5.89	5.68	2.67	6.37	3.45	0.87
Total Current Assets	115.98	80.13	185.59	287.15	375.08	99.55
Property, Plant & Equipment	5.59	3.87	2.2	1.15	0.15	0.07
Long-Term Investments	65.13	70.97	91.66	6.76	27.76	8.04
Goodwill	0.33	0.33	-	-	-	-
Other Intangible Assets	3.16	3.25	1.77	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	1.58
Other Long-Term Assets	5.6	0.85	0.95	3.13	7.34	0.34
Total Assets	195.78	159.39	293.48	305.44	414.17	111.55
Accounts Payable	2.71	2.62	4.59	2.4	6	3.08
Accrued Expenses	7.51	9.66	14.54	15.08	6.69	8.22
Current Portion of Long-Term Debt	14.49	9.36	-	-	-	-
Current Portion of Leases	0.29	0.48	0.28	0.18	-	-
Current Income Taxes Payable	0.11	0.19	0.72	2.22	8.14	1
Other Current Liabilities	3	2.65	-	0.01	0.1	-
Total Current Liabilities	28.5	24.95	20.12	19.9	20.94	12.3
Long-Term Debt	11.6	16.33	20.08	17.52	3.14	2.18
Long-Term Leases	2.59	0.73	0.99	0.04	-	-
Other Long-Term Liabilities	0.82	0.82	7.98	2.22	4.13	1.71
Total Liabilities	43.51	42.83	49.16	39.68	28.21	16.18
Common Stock	22.12	18.79	18.57	18.56	18	13.37
Additional Paid-In Capital	875.72	816.19	794.79	774.09	725.05	261.63
Retained Earnings	-726.64	-700.21	-550.94	-510.19	-357.8	-190
Comprehensive Income & Other	-19.15	-18.47	-19.46	-21.73	-8.34	5.82
Total Common Equity	152.05	116.3	242.96	260.74	376.91	90.82
Minority Interest	0.22	0.26	1.35	5.03	9.05	4.55
Shareholders' Equity	152.27	116.55	244.32	265.77	385.96	95.37
Total Liabilities & Equity	195.78	159.39	293.48	305.44	414.17	111.55
Total Debt	28.97	26.91	21.34	17.74	3.14	2.18
Net Cash (Debt)	69.24	35.42	157.92	255.37	359.12	95.07
Net Cash Growth	-16.72%	-77.57%	-38.16%	-28.89%	277.75%	217.90%
Net Cash Per Share	0.42	0.22	0.99	1.64	2.60	1.02
Filing Date Shares Outstanding	200.34	198.31	166.03	166.01	160.71	11.47
Total Common Shares Outstanding	199.78	167.96	166.03	165.94	160.68	11.47
Working Capital	87.48	55.17	165.47	267.25	354.15	87.25
Book Value Per Share	0.76	0.69	1.46	1.57	2.35	7.92
Tangible Book Value	148.57	112.72	241.19	260.74	376.91	90.82
Tangible Book Value Per Share	0.74	0.67	1.45	1.57	2.35	7.92
Machinery	2.93	2.93	1.13	-	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q